Abstract
Surveillance for colorectal cancer should aim to identify recurrence at a point when therapy, in the form of surgery and/or adjuvant therapy, could impact survival duration and/or quality of life (QOL). The identification of metachronous neoplasms and early diagnosis of other conditions also improves overall survival duration [1]. Standardized surveillance strategies are also important to provide information to drive quality improvement through audit of outcomes against professional and national standards.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tjandra J, Chan M. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum. 2007;50:1783–99.
National Health and Medical Research Council (NHMRC). Clinical practice guidelines for the Prevention, early detection and management of colorectal cancer. The Cancer Council Australia, Australian Cancer Network, The Commonwealth of Australia, Canberra 2005.
Yun H, Lee L, Park J, et al. Local recurrence after curative resection in patients with colon and rectal cancers. Int J Colorectal Dis. 2008;23:1081–7.
Worthington T, Wilson T, Padbury R. Case for postoperative surveillance following colorectal cancer resection. ANZ J Surg. 2004;74:43–5.
Anthony T, Simmang C, Hyman N, et al. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum. 2004;47:807–17.
Raptis DA, Gore DM, Boulos PB. The value of CEA and CT in early diagnosis of colorectal cancer recurrence. American Society of Colon and Rectal Surgeons Tripartite Meeting 2008. Oral presentation. Boston 2008.
Bruinvells D, Stiggerbart A, Kievet J, Van de Velde J. Follow-up of patients with colorectal cancer: a meta-analysis. Ann Surg. 1994;219:174–82.
Rosen M, Chan L, Beart R, Valksoin P, Anthone G. Follow-up of colorectal cancer: a meta analysis. Dis Colon Rectum. 1998;41:1116–25.
Renehan A, Egger M, O’Dwyer S. Impact on survival of intensive follow-up after curative resection for colorectal cancer: systemic review and meta-analysis of randomised trials. Br Med J. 2002;324:813–30.
Wattchow DA, Weller DP, Esterman A, Pilotto LS, McGorm K, Hammett Z, Platell C, Silagy C. General practice vs. surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer. 2006;94:116–21.
Ohlesson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma. Dis Colon Rectum. 1995;38:619–26.
Makela J, Laitnen S, Kairaluoma M. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomised trial. Arch Surg. 1995;130:1062–7.
Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology. 1998;114:7–14.
Rodriguez-Moranta F, Salo J, Arcusa A. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective multicenter, randomised, controlled trial. J Clin Oncol. 2006;24:386–93.
Peeters K, Marijnen C, Nagtegaal I, et al. The TME trial after a median follow up of 6 years. Ann Surg. 2007;246:693–701.
Borie F, Daures JP, Millat B, Tretarre B. Cost and effectiveness of follow-up examinations in patients with colorectal cancer resected for cure in a French population-based study. J Gastrointest Surg. 2004;8:552–8.
Hara M, Kanemitsu Y, Hirai T, Komori K, Kato T. Negative Serum CEA has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and post test probability in a follow-up study. Dis Colon Rectum. 2008;51:1675–80.
Howell J, Wotherspoon H, Leen E, coke T, McArdle C. Evaluation of a follow-up program after curative resection fro colorectal cancer. Br J Cancer. 1999;79:308–10.
Scott A, Gunawardana D, Kelley B, Stuckey J, Byrne A, Ramshaw J, Fulham M. PET Changes Management and Improves Prognostic Stratification in Patients with Recurrent Colorectal Cancer: Results of a Multicenter Prospective Study. J Nucl Med. 2008;49:1451–7.
Zakaria S, Donohue JH, Florenia G, Farnell MB, et al. Hepatic resection for colorectal metastases, value for risk scoring systems? Ann Surg. 2007;246:183–91.
Hideyuki I, Shimada H, Ohki S, Togo S, Yamaguchi S, Ichikawa Y. Results of aggressive resection of lung metastases from colorectal carcinoma detected by intensive follow-up. Dis Colon Rectum. 2002;45:468–75.
Heriot A, Byrne C, Lee P, Dobbs B, Tilney H, Solomon M, Mackay J, Frizelle F. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum. 2008;51:284–91.
Grossman EM, Johnson FE, Vigro KS, Longo WE, Fossati R. Follow-up of colorectal cancer patients after resection with curative intent: the GILDA trial. Surg Oncol. 2004;13:119–24.
Primrose J, Mant D. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patient who have undergone resection for colorectal cancer with curative intent. A protocol. Website -http://www.controlled-trials.com/isrctn/pf/61091474.
Yang I, Eschrich S, Bloom G, Quackenbush J, Yeatman T. Molecular profiling predicts colon cancer survival better than Dukes staging. Ann Surg Oncol. 2004;1 Suppl 2:S54.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Humana Press
About this chapter
Cite this chapter
El-Khoury, T., Solomon, M., Young, J. (2013). Colon and Rectum Carcinoma Surveillance Counterpoint: Australia. In: Johnson, F., et al. Patient Surveillance After Cancer Treatment. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-969-7_34
Download citation
DOI: https://doi.org/10.1007/978-1-60327-969-7_34
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60327-968-0
Online ISBN: 978-1-60327-969-7
eBook Packages: MedicineMedicine (R0)